Filing Details

Accession Number:
0001818382-24-000074
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-03 16:23:27
Reporting Period:
2024-05-30
Accepted Time:
2024-06-03 16:23:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1818382 Humacyte Inc. HUMA Biological Products, (No Disgnostic Substances) (2836) 851763759
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1877712 Ledbetter Heather Prichard 2525 East North Carolina Highway 54
Durham NC 27713
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-05-30 61,941 $7.71 2,625 No 4 S Direct
Common Stock Acquisiton 2024-05-30 78,779 $2.56 81,404 No 4 M Direct
Common Stock Disposition 2024-05-30 78,779 $8.36 2,625 No 4 S Direct
Common Stock Acquisiton 2024-05-30 48,166 $3.07 50,791 No 4 M Direct
Common Stock Disposition 2024-05-30 48,166 $8.32 2,625 No 4 S Direct
Common Stock Disposition 2024-05-31 2,625 $9.41 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (right to buy) Disposition 2024-05-30 78,779 $0.00 78,779 $2.56
Common Stock Stock Options (right to buy) Disposition 2024-05-30 48,166 $0.00 48,166 $3.07
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-12-11 2025-12-11 No 4 M Direct
87,834 2024-05-08 2032-12-08 No 4 M Direct
Footnotes
  1. The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $8.36 to $8.44. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $8.31 to $8.42. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.